{"nct_id":"NCT03167164","title":"QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy","status":"WITHDRAWN","status_verified_date":"2017-10","start_date":"2017-12","start_date_type":"ESTIMATED","primary_completion_date":"2019-01","primary_completion_date_type":"ESTIMATED","completion_date":"2021-12-28","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["IBRX"]}